Erschienen in:
24.07.2019 | Editorial
The HCV Treatment Cascade: Race Is a Factor to Consider
verfasst von:
Maya Balakrishnan, MD, MPH, Fasiha Kanwal, MD, MSHS
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 10/2019
Einloggen, um Zugang zu erhalten
Excerpt
Chronic hepatitis C is the most common blood-borne viral infection in the USA and a leading cause of chronic liver disease, liver failure, and hepatocellular carcinoma (HCC). The complications of HCV infection are preventable. Antiviral treatment with sustained virological response (SVR) is associated with a 71–76% reduction in HCC risk
1 and a 74% reduction in risk of death compared to ongoing active infection.
2 …